Welgene Biotech Co.,Ltd. (TPEX:6661)
Taiwan
· Delayed Price · Currency is TWD 18.15
-0.15 (-0.82%)
Apr 29, 2026, 1:30 PM CST
Welgene Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 423 | 433 | 555 | 521 | 517 | 570 | Upgrade
|
| Market Cap Growth | -21.09% | -21.85% | 6.49% | 0.68% | -9.20% | -23.98% | Upgrade
|
| Enterprise Value | 386 | 350 | 499 | 500 | 317 | 410 | Upgrade
|
| Last Close Price | 18.15 | 18.60 | 23.80 | 22.35 | 22.02 | 23.69 | Upgrade
|
| PE Ratio | 318.02 | 325.91 | 501.03 | - | 54.16 | 41.58 | Upgrade
|
| PS Ratio | 1.13 | 1.15 | 1.72 | 1.86 | 1.61 | 1.82 | Upgrade
|
| PB Ratio | 1.48 | 1.52 | 1.88 | 1.74 | 1.70 | 1.84 | Upgrade
|
| P/TBV Ratio | 1.51 | 1.54 | 1.93 | 1.79 | 1.71 | 1.85 | Upgrade
|
| P/FCF Ratio | - | - | 10.82 | - | 21.06 | 82.94 | Upgrade
|
| P/OCF Ratio | 11.99 | 12.29 | 9.89 | - | 10.06 | 50.67 | Upgrade
|
| EV/Sales Ratio | 1.03 | 0.93 | 1.55 | 1.78 | 0.99 | 1.31 | Upgrade
|
| EV/EBITDA Ratio | 13.87 | 12.55 | 34.31 | 52.76 | 12.97 | 18.46 | Upgrade
|
| EV/EBIT Ratio | - | 2758.71 | - | - | 18.34 | 28.69 | Upgrade
|
| EV/FCF Ratio | -63.61 | - | 9.73 | - | 12.90 | 59.72 | Upgrade
|
| Debt / Equity Ratio | 0.79 | 0.79 | 0.44 | 0.51 | 0.17 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 8.11 | 8.11 | 4.66 | 6.77 | 1.42 | 0.72 | Upgrade
|
| Debt / FCF Ratio | - | - | 2.53 | - | 2.08 | 3.47 | Upgrade
|
| Net Debt / Equity Ratio | -0.14 | -0.14 | -0.33 | -0.14 | -0.55 | -0.64 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.46 | -1.46 | -6.65 | -4.51 | -6.81 | -8.98 | Upgrade
|
| Net Debt / FCF Ratio | 6.72 | 6.72 | -1.88 | 1.52 | -6.77 | -29.06 | Upgrade
|
| Asset Turnover | 0.65 | 0.65 | 0.60 | 0.57 | 0.75 | 0.80 | Upgrade
|
| Inventory Turnover | 5.79 | 5.79 | 4.12 | 3.67 | 5.91 | 7.91 | Upgrade
|
| Quick Ratio | 1.92 | 1.92 | 2.02 | 1.93 | 2.53 | 2.72 | Upgrade
|
| Current Ratio | 2.21 | 2.21 | 2.34 | 2.39 | 2.89 | 2.99 | Upgrade
|
| Return on Equity (ROE) | 0.45% | 0.45% | 0.24% | -1.04% | 3.11% | 4.87% | Upgrade
|
| Return on Assets (ROA) | 0.01% | 0.01% | -0.10% | -0.54% | 2.51% | 2.28% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.06% | 0.06% | -0.21% | -2.16% | 9.82% | 11.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.00% | 0.00% | -0.20% | -1.00% | 5.20% | 4.60% | Upgrade
|
| Earnings Yield | 0.31% | 0.31% | 0.20% | -0.51% | 1.85% | 2.40% | Upgrade
|
| FCF Yield | -1.44% | -1.40% | 9.24% | -5.39% | 4.75% | 1.21% | Upgrade
|
| Dividend Yield | - | - | - | - | 0.82% | 2.03% | Upgrade
|
| Payout Ratio | - | - | - | - | 118.16% | 187.38% | Upgrade
|
| Buyback Yield / Dilution | 4.88% | 4.88% | - | 0.10% | -0.93% | -10.99% | Upgrade
|
| Total Shareholder Return | 4.88% | 4.88% | - | 0.10% | -0.11% | -8.97% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.